Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 February 2022 | Story Lacea Loader | Photo Sonia Small (Kaleidoscope Studios)
Dr Engela van Staden
Dr Engela van Staden, Vice Rector: Academic

The University of the Free State (UFS) has finalised the first part of the Council on Higher Education (CHE) Institutional Audit (IA), submitting its Institutional Self-Evaluation Report (SER) and Portfolio of Evidence (PoE) to the higher education quality assurance body. 

According to Dr Engela van Staden, Vice-Rector: Academic, the second part of the institutional audit will involve the participation of relevant stakeholders in a site visit to the institution. During the visit, scheduled between 9 and 13 May 2022, an external panel of experts will systematically assess the submitted SER and requisite documents by asking inquisitive questions to interviewees who will be participating in this process.  

“The focus will be on the quality of programme offerings with a view to improving student success in all spheres of the student walk – from registration to graduation. To this end, the university’s Integrated Quality Management Framework (IQMF) will be assessed in order to provide evidence that quality assurance is ingrained in the core functions of the UFS, i.e., student success; quality of teaching and research; and engaged scholarship.”

Dr Van Staden says by re-introducing the SER, the university will embark on a stakeholder engagement plan, engaging with staff in faculties, service units, directorates, centres, departments, or schools, to keep them informed and prepared for a productive contribution to the Institutional Audit process. 

- The CHE is an independent statutory body established in terms of the provisions of the Higher Education Act No. 101 of 1997, as amended. It advises the Minister responsible for Higher Education and Training and is the national authority for quality assurance and promotion in higher education.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept